Pilot study aims to regrow hair for young survivors
NCT ID NCT05778825
Summary
This study is testing whether a pill form of minoxidil can safely help regrow hair in children and young adults who have persistent hair loss after finishing cancer treatment. It will involve about 10 participants aged 6 to 18 who completed cancer therapy at least a year ago. Researchers will measure changes in hair density and monitor side effects and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.